ITAYA Trademark
Trademark Overview
On Wednesday, June 22, 2022, a trademark application was filed for ITAYA with the United States Patent and Trademark Office. The USPTO has given the ITAYA trademark a serial number of 97469880. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Wednesday, September 17, 2025. This trademark is owned by Eli Lilly and Company. The ITAYA trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascula...
General Information
| Serial Number | 97469880 |
| Word Mark | ITAYA |
| Filing Date | Wednesday, June 22, 2022 |
| Status | 730 - FIRST EXTENSION - GRANTED |
| Status Date | Wednesday, September 17, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, February 11, 2025 |
Trademark Statements
| Goods and Services | Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, July 9, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Eli Lilly and Company |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Indianapolis, IN 46285 |
| Party Name | Eli Lilly and Company |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Indianapolis, IN 46285 |
Trademark Events
| Event Date | Event Description |
| Tuesday, April 4, 2023 | NON-FINAL ACTION WRITTEN |
| Tuesday, April 4, 2023 | NON-FINAL ACTION E-MAILED |
| Tuesday, April 4, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Saturday, June 25, 2022 | NEW APPLICATION ENTERED |
| Saturday, July 9, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, April 4, 2023 | ASSIGNED TO EXAMINER |
| Wednesday, June 7, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, June 7, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, June 7, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, June 27, 2023 | SUSPENSION LETTER WRITTEN |
| Tuesday, June 27, 2023 | LETTER OF SUSPENSION E-MAILED |
| Tuesday, June 27, 2023 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Tuesday, January 2, 2024 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Wednesday, February 5, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Monday, January 6, 2025 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
| Tuesday, January 21, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, February 11, 2025 | PUBLISHED FOR OPPOSITION |
| Tuesday, April 8, 2025 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, February 11, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Wednesday, September 17, 2025 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, September 17, 2025 | SOU EXTENSION 1 FILED |
| Wednesday, September 17, 2025 | SOU EXTENSION 1 GRANTED |
| Thursday, September 18, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
